NexGenix is a privately-held drug discovery and development company focused on the "next generation" of targeted therapies for cancer and diseases of the nervous system such as glioblastoma, neurodegenerative diseases, neurofibromatosis, and autism-spectrum disorders. The Company has acquired, through in-licensing and research collaboration, a robust structural chemistry platform in resorcylic macrolides, highly potent inhibitors of the chaperone, heat shock protein 90 (Hsp90). The concept that numerous diseases, including cancer, neurofibromatosis, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and Parkinson's disease involve misregulation of protein homeostasis presents a unique opportunity for drug development for these varied disorders. NexGenix's novel Hsp90 inhibitors, based on the highly potent compound radicicol, exhibit the potential to be best in class drugs. NexGenix has world-class scientific advisors and collaborators in the areas of protein folding, kinase signaling and oncogenesis, and neurodegenerative diseases. The company additionally has a growing portfolio of intellectual property covering its key efforts.
View Top Employees from NexGenix PharmaceuticalsWebsite | http://www.nexgenixpharm.com |
Revenue | $5.2 million |
Employees | 4 (4 on RocketReach) |
Founded | 2003 |
Address | 30 E 85th St Ste 3B, New York, New York 10028, US |
Phone | (917) 210-3377 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Pharmaceuticals, Manufacturing, Science and Engineering, Drug Discovery, Medical, Health Care |
SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular NexGenix Pharmaceuticals employee's phone or email?
The NexGenix Pharmaceuticals annual revenue was $5.2 million in 2024.
Ruihong Chen is the Director of NexGenix Pharmaceuticals.
4 people are employed at NexGenix Pharmaceuticals.
NexGenix Pharmaceuticals is based in New York, New York.
The NAICS codes for NexGenix Pharmaceuticals are [325, 32, 32541, 3254].
The SIC codes for NexGenix Pharmaceuticals are [28, 283, 2834].